Epidemiology of Prostate Cancer: Current Status
The disease is more common among older men, with a median age at diagnosis above 60 years.
Prostate cancer is one of the most common cancers affecting men worldwide. Its worldwide incidence and mortality vary considerably, largely reflecting differences in PSA testing and screening practices. The disease is predominantly a disease of older men, with median diagnosis age exceeding 60 years. Epidemiological studies highlight geographic, racial, and socioeconomic factors contributing to these disparities.
Understanding the epidemiology of prostate cancer—including its age‑specific incidence, geographic variation, and risk factors—is essential for optimizing screening protocols, allocating resources, and developing targeted prevention strategies in diverse populations.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Apalutamide Treatment and Metastasis‑free Survival in Prostate Cancer
- The prostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines
- The contemporary management of prostate cancer
- Extracellular TROP2 Fragment Identified as a Potential Biomarker and Metastasis Driver
- Overall survival of prostate cancer patients treated with Lu‑177 PSMA 617 (Pluvicto®) in a multidisciplinary setting— a single center experience